BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28427560)

  • 1. Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation.
    Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Maddalena F; Condelli V; Landriscina M; Esposito F
    Adv Protein Chem Struct Biol; 2017; 108():163-198. PubMed ID: 28427560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.
    Matassa DS; Amoroso MR; Lu H; Avolio R; Arzeni D; Procaccini C; Faicchia D; Maddalena F; Simeon V; Agliarulo I; Zanini E; Mazzoccoli C; Recchi C; Stronach E; Marone G; Gabra H; Matarese G; Landriscina M; Esposito F
    Cell Death Differ; 2016 Sep; 23(9):1542-54. PubMed ID: 27206315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol Homeostasis Modulates Platinum Sensitivity in Human Ovarian Cancer.
    Criscuolo D; Avolio R; Calice G; Laezza C; Paladino S; Navarra G; Maddalena F; Crispo F; Pagano C; Bifulco M; Landriscina M; Matassa DS; Esposito F
    Cells; 2020 Mar; 9(4):. PubMed ID: 32235572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer.
    Avolio R; Matassa DS; Criscuolo D; Landriscina M; Esposito F
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition.
    Amoroso MR; Matassa DS; Agliarulo I; Avolio R; Lu H; Sisinni L; Lettini G; Gabra H; Landriscina M; Esposito F
    Cell Death Dis; 2016 Dec; 7(12):e2522. PubMed ID: 27977010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.
    Landriscina M; Amoroso MR; Piscazzi A; Esposito F
    Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells.
    Sisinni L; Maddalena F; Lettini G; Condelli V; Matassa DS; Esposito F; Landriscina M
    Int J Oncol; 2014 Feb; 44(2):573-82. PubMed ID: 24297638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.
    Agliarulo I; Matassa DS; Amoroso MR; Maddalena F; Sisinni L; Sepe L; Ferrari MC; Arzeni D; Avolio R; Paolella G; Landriscina M; Esposito F
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2570-9. PubMed ID: 26071104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Ai Z; Lu Y; Qiu S; Fan Z
    Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas.
    Maddalena F; Condelli V; Matassa DS; Pacelli C; Scrima R; Lettini G; Li Bergolis V; Pietrafesa M; Crispo F; Piscazzi A; Storto G; Capitanio N; Esposito F; Landriscina M
    Mol Oncol; 2020 Dec; 14(12):3030-3047. PubMed ID: 33025742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
    Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
    Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor.
    Matassa DS; Agliarulo I; Avolio R; Landriscina M; Esposito F
    Genes (Basel); 2018 Apr; 9(4):. PubMed ID: 29621137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.
    Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D
    BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon Cancer Cells.
    Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells.
    Rasola A; Neckers L; Picard D
    Trends Cell Biol; 2014 Aug; 24(8):455-63. PubMed ID: 24731398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.
    Deng J; Wang L; Chen H; Hao J; Ni J; Chang L; Duan W; Graham P; Li Y
    Oncotarget; 2016 Aug; 7(34):55771-55788. PubMed ID: 27304054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium.
    Aust S; Bachmayr-Heyda A; Pateisky P; Tong D; Darb-Esfahani S; Denkert C; Chekerov R; Sehouli J; Mahner S; Van Gorp T; Vergote I; Speiser P; Horvat R; Zeillinger R; Pils D
    Mol Cancer; 2012 Sep; 11():69. PubMed ID: 22978347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: a therapeutic implication.
    Suh DH; Kim HS; Kim B; Song YS
    Biochem Pharmacol; 2014 Nov; 92(1):43-54. PubMed ID: 25168677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of tumor necrosis factor receptor associated protein 1 in epithelial ovarian cancer].
    Ma RQ; Cheng HY; Ye X; Chen J; Cui H; Wei LH; Chang XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 46(1):120-4. PubMed ID: 24535363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.